[{"indications": "Indications\u00a0hypertension", "name": "ISRADIPINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.6 Nitrates, calcium-channel blockers, and other antianginal drugs", "2.6.2 Calcium-channel blockers"], "cautions": "Cautions\u00a0sick sinus syndrome (if pacemaker not\r\nfitted); severe aortic stentosis; poor\r\ncardiac reserve; chronic heart failure; interactions: Appendix 1 (calcium-channel blockers)", "side-effects": "Side-effects\u00a0abdominal discomfort; tachycardia, palpitation,\r\nflushing, peripheral oedema; dyspnoea; headache, fatigue, dizziness;\r\npolyuria; rash; less commonly hypotension, weight\r\ngain; very rarely vomiting, nausea, gum hyperplasia,\r\nanorexia, drowsiness, arrhythmia, bradycardia, heart failure, cough,\r\ndepression, paraesthesia, anxiety, erectile dysfunction, blood disorders\r\n(such as thrombocytopenia, leucopenia, anaemia), arthralgia, visual\r\ndisturbance, hypersensitivity reactions; hepatitis and gynaecomastia\r\nalso reported; overdosage, see Emergency Treatment of Poisoning", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2685.htm", "doses": ["2.5\u00a0mg twice daily, increased if necessary after 3\u20134 weeks\r\nto 5\u00a0mg twice daily (exceptionally up to 10\u00a0mg twice daily); elderly 1.25\u00a0mg twice daily, increased if necessary\r\nafter 3\u20134 weeks according to response; maintenance dose of 2.5\u00a0mg\r\nor 5\u00a0mg once daily may be sufficient"], "pregnancy": "Pregnancy\u00a0may inhibit labour; risk to fetus should be balanced\r\nagainst risk of uncontrolled maternal hypertension"}]